Companies ›Materials ›STE.V

STE.V — TSX Venture Diversified Mining

Ste.V

$0,41

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

—

ROE

-6,7 %

Net margin

—

Debt / equity

0,00

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

$216,88

Open

—

Next earnings

2026-07-28

Ex-dividend

—

TR 1Y

—

About

STE.V operates in the Diversified Mining industry, extracting and processing various minerals and metals for industrial and commercial applications.

Business. STE.V operates in the Diversified Mining industry, extracting and processing various minerals and metals for industrial and commercial applications.

Classification92 %

SectorBasic Materials

Business sectorMineral Resources

IndustryDiversified Mining

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

EarningsQ1 2026 earnings (expected)2026-07-28 · estimated

See all catalysts →

At a glance

Score→

composite score

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning STE.

Sector rotation

Sector1D1Mvs mkt

Communication Services+2,2 %−5,5 %+1,5 %

Materials · THIS SECTOR+2,2 %+3,2 %+1,4 %

Energy+0,9 %+5,2 %+0,1 %

Health Care+0,7 %−1,3 %+0,0 %

Consumer Discretionary+0,3 %+9,2 %−0,4 %

Information Technology+0,2 %+8,1 %−0,6 %

Financials−0,5 %−3,0 %−1,2 %

Consumer Staples−0,6 %+3,3 %−1,4 %

Real Estate−0,7 %+10,9 %−1,4 %

Industrials−1,1 %−0,3 %−1,8 %

Utilities−1,9 %+28,2 %−2,6 %

Developing storylines

No tracked sagas currently linked to STE.V. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-07-24 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ1 2026 earnings (expected)2026-07-28 · estimated
Macro
Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR
Congressional trades
CongressApril McClain Delaney — STERIS plc2026-04-30 · MD · Purchase · $1,001 - $15,000
CongressApril McClain Delaney — STERIS plc2026-03-16 · MD · Purchase · $1,001 - $15,000
CongressApril McClain Delaney — STERIS plc2026-02-06 · MD · Purchase · $1,001 - $15,000
CongressApril McClain Delaney — STERIS plc2025-09-18 · MD · Purchase · $1,001 - $15,000
CongressApril McClain Delaney — STERIS plc2025-09-11 · MD · Purchase · $1,001 - $15,000
CongressApril McClain Delaney — STERIS plc2025-06-26 · MD · Sale · $1,001 - $15,000

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Composite score18 / 100

Composite score 0-100 · Data quality 0,55

Data quality0,55 / 1.00

Synthesis

Business

STE.V operates in the Diversified Mining industry, extracting and processing various minerals and metals for industrial and commercial applications.

Classification92 %

SectorBasic Materials

Business sectorMineral Resources

IndustryDiversified Mining

AI synthesis

GENERATED

STE.V's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is weak, as evidenced by a current ratio of 0.23, suggesting limited short-term liquidity to cover immediate liabilities. The company's free cash flow is negative at -967,570 CAD, reflecting a lack of cash generation from operations.

In terms of profitability, STE.V is underperforming, with a return on equity of -6.66% and a return on assets of -5.5%, both significantly below industry benchmarks for Diversified Mining. The company's operating income and net income are both negative, at -798,590 CAD and -967,570 CAD, respectively, indicating a loss-making position.

STE.V's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess the concentration of its revenue streams. The company's exposure to specific markets or products is not disclosed, which limits the ability to evaluate its diversification strategy.

The company's growth trajectory is uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. The negative operating and net income figures suggest a challenging operating environment, with no clear indication of improvement in the near term.

STE.V's risk profile is marked by low liquidity and low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is currently free of long-term debt, which reduces the risk of financial distress. However, the absence of positive cash flow from operations remains a concern.

There are no recent events or filings disclosed in the available data that would provide insight into STE.V's operational or financial developments. The lack of recent disclosures limits the ability to assess the company's current strategic direction or performance.

Key takeaways

STE.V is currently operating at a loss, with negative operating and net income figures.
The company's liquidity position is weak, as indicated by a low current ratio.
STE.V has no long-term debt, which reduces its financial risk.
The company's profitability metrics are significantly below industry benchmarks.
There is no recent information available to assess STE.V's strategic direction or performance.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

$0,41

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$14.5M

Net cashⓘ

—

Current ratioⓘ

0.2

Debt / equityⓘ

0.0

ROAⓘ

-5.5%

ROEⓘ

-6.7%

Cash conversionⓘ

87.0%

CapEx / revenueⓘ

—

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

Business relationships153 disclosed relationships · 1 type · extracted from filings & disclosures

Subsidiaries153

EX21:014266a18f50EX21:014266a18f50Subsidiarie97%

EX21:02495c5ecde2EX21:02495c5ecde2Subsidiarie97%

EX21:041c2e122c29EX21:041c2e122c29Subsidiarie97%

EX21:044cbcfee5e4EX21:044cbcfee5e4Subsidiarie97%

EX21:069f9bba675bEX21:069f9bba675bSubsidiarie97%

EX21:074bdb3bca8dEX21:074bdb3bca8dSubsidiarie97%

EX21:07a74d55565fEX21:07a74d55565fSubsidiarie97%

EX21:0af0365f7173EX21:0af0365f7173Subsidiarie97%

EX21:0b35f8a98c9dEX21:0b35f8a98c9dSubsidiarie97%

EX21:0ff4e78fa2c3EX21:0ff4e78fa2c3Subsidiarie97%

EX21:116cd09e5112EX21:116cd09e5112Subsidiarie97%

EX21:12bc14d1a925EX21:12bc14d1a925Subsidiarie97%

EX21:1326b78a609bEX21:1326b78a609bSubsidiarie97%

EX21:14568c6107aeEX21:14568c6107aeSubsidiarie97%

EX21:145e642b0eb4EX21:145e642b0eb4Subsidiarie97%

EX21:146b15073219EX21:146b15073219Subsidiarie97%

EX21:1cad51cd305eEX21:1cad51cd305eSubsidiarie97%

EX21:1f02c298a1e8EX21:1f02c298a1e8Subsidiarie97%

EX21:208be51038e1EX21:208be51038e1Subsidiarie97%

EX21:20e1fff93882EX21:20e1fff93882Subsidiarie97%

EX21:2195d25c16ecEX21:2195d25c16ecSubsidiarie97%

EX21:220b59b9a1c8EX21:220b59b9a1c8Subsidiarie97%

EX21:23c0dde8d6e5EX21:23c0dde8d6e5Subsidiarie97%

EX21:24f93c87d8b6EX21:24f93c87d8b6Subsidiarie97%

EX21:26d2988d1a74EX21:26d2988d1a74Subsidiarie97%

EX21:2a9481546705EX21:2a9481546705Subsidiarie97%

EX21:2ae4e475adcbEX21:2ae4e475adcbSubsidiarie97%

EX21:2db279ffdaa8EX21:2db279ffdaa8Subsidiarie97%

EX21:2ef16b0380d5EX21:2ef16b0380d5Subsidiarie97%

EX21:33e6b1bd7856EX21:33e6b1bd7856Subsidiarie97%

EX21:355fdf6d5dbeEX21:355fdf6d5dbeSubsidiarie97%

EX21:359dd0a66473EX21:359dd0a66473Subsidiarie97%

EX21:35c64fdfa270EX21:35c64fdfa270Subsidiarie97%

EX21:36160b8382e7EX21:36160b8382e7Subsidiarie97%

EX21:36d36542db83EX21:36d36542db83Subsidiarie97%

EX21:3bb86c4c7d06EX21:3bb86c4c7d06Subsidiarie97%

EX21:3e3b0b4c2ce8EX21:3e3b0b4c2ce8Subsidiarie97%

EX21:406c3a6bdd7dEX21:406c3a6bdd7dSubsidiarie97%

EX21:41e7b2c8c467EX21:41e7b2c8c467Subsidiarie97%

EX21:4204891ffd58EX21:4204891ffd58Subsidiarie97%

EX21:450383496096EX21:450383496096Subsidiarie97%

EX21:4606a0637202EX21:4606a0637202Subsidiarie97%

EX21:466bdd5c33faEX21:466bdd5c33faSubsidiarie97%

EX21:49a9aa53c12cEX21:49a9aa53c12cSubsidiarie97%

EX21:4ab66b1c09f9EX21:4ab66b1c09f9Subsidiarie97%

EX21:4ce732e4afa7EX21:4ce732e4afa7Subsidiarie97%

EX21:5627eeb11c85EX21:5627eeb11c85Subsidiarie97%

EX21:56a699a66f92EX21:56a699a66f92Subsidiarie97%

EX21:56d9333356bcEX21:56d9333356bcSubsidiarie97%

EX21:607f29b07a4eEX21:607f29b07a4eSubsidiarie97%

EX21:63aa1b12faa9EX21:63aa1b12faa9Subsidiarie97%

EX21:63fad8bd13e7EX21:63fad8bd13e7Subsidiarie97%

EX21:64b35c3cabe4EX21:64b35c3cabe4Subsidiarie97%

EX21:6605832cec87EX21:6605832cec87Subsidiarie97%

EX21:66bc621ef660EX21:66bc621ef660Subsidiarie97%

EX21:6b1ea6086026EX21:6b1ea6086026Subsidiarie97%

EX21:6f5460618d82EX21:6f5460618d82Subsidiarie97%

EX21:6f79c3761cfaEX21:6f79c3761cfaSubsidiarie97%

EX21:71049864b904EX21:71049864b904Subsidiarie97%

EX21:73a213a20958EX21:73a213a20958Subsidiarie97%

EX21:7430522158adEX21:7430522158adSubsidiarie97%

EX21:745dc72c5081EX21:745dc72c5081Subsidiarie97%

EX21:75b05186eb34EX21:75b05186eb34Subsidiarie97%

EX21:79b4496ac341EX21:79b4496ac341Subsidiarie97%

EX21:7a6d79b40976EX21:7a6d79b40976Subsidiarie97%

EX21:7a89737cace5EX21:7a89737cace5Subsidiarie97%

EX21:7e338c8c8912EX21:7e338c8c8912Subsidiarie97%

EX21:7e5ca0e34c8eEX21:7e5ca0e34c8eSubsidiarie97%

EX21:7e636867cc6eEX21:7e636867cc6eSubsidiarie97%

EX21:7eccf609024cEX21:7eccf609024cSubsidiarie97%

EX21:81d1935e88f5EX21:81d1935e88f5Subsidiarie97%

EX21:86283d6e44ddEX21:86283d6e44ddSubsidiarie97%

EX21:87aa000a2eaaEX21:87aa000a2eaaSubsidiarie97%

EX21:88baeae735bcEX21:88baeae735bcSubsidiarie97%

EX21:8a15406eeac2EX21:8a15406eeac2Subsidiarie97%

EX21:8e11bc0b36d4EX21:8e11bc0b36d4Subsidiarie97%

EX21:8f79c7512becEX21:8f79c7512becSubsidiarie97%

EX21:9075ae5144deEX21:9075ae5144deSubsidiarie97%

EX21:90ad78636850EX21:90ad78636850Subsidiarie97%

EX21:91723a251d3dEX21:91723a251d3dSubsidiarie97%

EX21:93865999b95aEX21:93865999b95aSubsidiarie97%

EX21:93da292e9de6EX21:93da292e9de6Subsidiarie97%

EX21:9560fdc24af7EX21:9560fdc24af7Subsidiarie97%

EX21:956d835cd737EX21:956d835cd737Subsidiarie97%

EX21:96c9ab696eadEX21:96c9ab696eadSubsidiarie97%

EX21:979d11c4a229EX21:979d11c4a229Subsidiarie97%

EX21:984bb0ce9091EX21:984bb0ce9091Subsidiarie97%

EX21:98aa5bf235c2EX21:98aa5bf235c2Subsidiarie97%

EX21:98e9508e8ba2EX21:98e9508e8ba2Subsidiarie97%

EX21:9ab5d2a0469cEX21:9ab5d2a0469cSubsidiarie97%

EX21:9d67c6c26f63EX21:9d67c6c26f63Subsidiarie97%

EX21:9ffcb3c9a494EX21:9ffcb3c9a494Subsidiarie97%

EX21:a318eeb97176EX21:a318eeb97176Subsidiarie97%

EX21:a319e184dd0dEX21:a319e184dd0dSubsidiarie97%

EX21:a854ec0e60ceEX21:a854ec0e60ceSubsidiarie97%

EX21:aabcaf1500cfEX21:aabcaf1500cfSubsidiarie97%

EX21:ab5a9687eee8EX21:ab5a9687eee8Subsidiarie97%

EX21:ac3486f2d509EX21:ac3486f2d509Subsidiarie97%

EX21:ad6623f6060bEX21:ad6623f6060bSubsidiarie97%

EX21:add3e9458dcbEX21:add3e9458dcbSubsidiarie97%

EX21:afc4b253d9f3EX21:afc4b253d9f3Subsidiarie97%

EX21:b007701aa44aEX21:b007701aa44aSubsidiarie97%

EX21:b0c1d842b6e2EX21:b0c1d842b6e2Subsidiarie97%

EX21:b19bc8e3ffb5EX21:b19bc8e3ffb5Subsidiarie97%

EX21:b22a11e5512cEX21:b22a11e5512cSubsidiarie97%

EX21:b35f738df3faEX21:b35f738df3faSubsidiarie97%

EX21:b594b8068312EX21:b594b8068312Subsidiarie97%

EX21:b5be570b57deEX21:b5be570b57deSubsidiarie97%

EX21:b622e6f1b0b4EX21:b622e6f1b0b4Subsidiarie97%

EX21:b81e3ba58311EX21:b81e3ba58311Subsidiarie97%

EX21:b8f9e62f2693EX21:b8f9e62f2693Subsidiarie97%

EX21:b985a141615eEX21:b985a141615eSubsidiarie97%

EX21:c1ba7c9df643EX21:c1ba7c9df643Subsidiarie97%

EX21:c1f30de389baEX21:c1f30de389baSubsidiarie97%

EX21:c3787d229e98EX21:c3787d229e98Subsidiarie97%

EX21:c4553e917175EX21:c4553e917175Subsidiarie97%

EX21:c46977484b49EX21:c46977484b49Subsidiarie97%

EX21:c6437c5d0dd8EX21:c6437c5d0dd8Subsidiarie97%

EX21:c6624154422fEX21:c6624154422fSubsidiarie97%

EX21:c7330c21fb5aEX21:c7330c21fb5aSubsidiarie97%

EX21:c747e822da1eEX21:c747e822da1eSubsidiarie97%

EX21:c7cccace60f4EX21:c7cccace60f4Subsidiarie97%

EX21:c7d6b73bc0dfEX21:c7d6b73bc0dfSubsidiarie97%

EX21:ca535d22c7f3EX21:ca535d22c7f3Subsidiarie97%

EX21:ca5db27ade48EX21:ca5db27ade48Subsidiarie97%

EX21:ca5e185471adEX21:ca5e185471adSubsidiarie97%

EX21:ca9d09c8af01EX21:ca9d09c8af01Subsidiarie97%

EX21:cae26f535c28EX21:cae26f535c28Subsidiarie97%

EX21:cba1fa9db05cEX21:cba1fa9db05cSubsidiarie97%

EX21:d0da2d9ad8b7EX21:d0da2d9ad8b7Subsidiarie97%

EX21:d2d37bdbac47EX21:d2d37bdbac47Subsidiarie97%

EX21:d5c298f5d4dfEX21:d5c298f5d4dfSubsidiarie97%

EX21:d64bf1d61391EX21:d64bf1d61391Subsidiarie97%

EX21:d65a86b9d20fEX21:d65a86b9d20fSubsidiarie97%

EX21:d837f8643c8bEX21:d837f8643c8bSubsidiarie97%

EX21:dab1d390142fEX21:dab1d390142fSubsidiarie97%

EX21:dad8cd6901d2EX21:dad8cd6901d2Subsidiarie97%

EX21:dec8c122afa3EX21:dec8c122afa3Subsidiarie97%

EX21:e1f669e0b281EX21:e1f669e0b281Subsidiarie97%

EX21:e5a61ae4e548EX21:e5a61ae4e548Subsidiarie97%

EX21:e75c5876ad33EX21:e75c5876ad33Subsidiarie97%

EX21:e9e1df75484dEX21:e9e1df75484dSubsidiarie97%

EX21:ef61aa7912c8EX21:ef61aa7912c8Subsidiarie97%

EX21:f0f83d4a5477EX21:f0f83d4a5477Subsidiarie97%

EX21:f30fd6a1a2ebEX21:f30fd6a1a2ebSubsidiarie97%

EX21:f5202713a225EX21:f5202713a225Subsidiarie97%

EX21:f5d41ace7fccEX21:f5d41ace7fccSubsidiarie97%

EX21:f6c3f57e5e5cEX21:f6c3f57e5e5cSubsidiarie97%

EX21:f6f26028d198EX21:f6f26028d198Subsidiarie97%

EX21:f73e3723bc58EX21:f73e3723bc58Subsidiarie97%

EX21:f9b82541ee0bEX21:f9b82541ee0bSubsidiarie97%

EX21:fc554a1c9359EX21:fc554a1c9359Subsidiarie97%

EX21:ff2ebe5ccb3cEX21:ff2ebe5ccb3cSubsidiarie97%

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Corporate eventM&A horizon

M&A probabilityconf 3 %

Probability

3 %

Base rate

3 %

Band

—

180-day horizon · target 2027-01-19 · 1,0× base rate

No acquirer candidates identified by the signal model.

Probabilistic model output — not investment advice. · generated 2026-07-23

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskLow

Filing-based flags

No immediate filing-based liquidity or dilution flags were detected.

Benchmarks vs cohort

ROE-6,7 %Above median

D/E0,00Above median

Cash Conv0,87Above median

Corporate actions / M&A

M&A probabilityconf —

Probability

3 %

Base rate

3 %

Band

Low

180-day horizon · target 2027-01-19 · 1,0× base rate

No acquirer candidates identified by the signal model.

Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

Derivative transactions

Net acquired 162 534 sh1 exercises · 10 grants11 insiders

Sohi MohsenDirector · Director Stock Option (right to buy) → Ordinary SharesDisposed 3 781 @ $71,40exercise · 2026-07-01
Majors Cary LSVP and President, Healthcare · Employee Stock Option (right to buy) → Ordinary SharesAcquired 16 548 @ $230,74grant · 2026-06-02
Madsen JuliaSr. VP and GM, Life Sciences · Employee Stock Option (right to buy) → Ordinary SharesAcquired 8 080 @ $230,74grant · 2026-06-02
Zangerle John AdamSr. VP, Gen Counsel, and Sec. · Employee Stock Option (right to buy) → Ordinary SharesAcquired 15 200 @ $230,74grant · 2026-06-02
Tamaro RenatoV.P. & Corporate Treasurer · Employee Stock Option (right to buy) → Ordinary SharesAcquired 2 620 @ $230,74grant · 2026-06-02
Kohler Kenneth ESVP & GM, AST · Employee Stock Option (right to buy) → Ordinary SharesAcquired 7 668 @ $230,74grant · 2026-06-02
Fraser Mary ClareSVP & Chief HRO · Employee Stock Option (right to buy) → Ordinary SharesAcquired 10 492 @ $230,74grant · 2026-06-02
McGowan LindseyVP, Chf. Comp. & Quality Offc. · Employee Stock Option (right to buy) → Ordinary SharesAcquired 4 036 @ $230,74grant · 2026-06-02
Carestio Daniel ADirector, President and CEO · Employee Stock Option (right to buy) → Ordinary SharesAcquired 82 740 @ $230,74grant · 2026-06-02
Burton Karen LSr. Vice Pres., CFO · Employee Stock Option (right to buy) → Ordinary SharesAcquired 18 564 @ $230,74grant · 2026-06-02
Boulud PierreDirector · Career Restricted Stock Units → Ordinary SharesAcquired 367grant · 2026-06-02

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income
Return On Assets
net_income / total_assets

Source documents

STE.V Market data — financials · 2026-05-29

Ownership & reference

Leadership

Johnathan MoreChairman of the Board, Chief Executive Officer

Insider activity

Net selling0 buys · 3 sellsnet -$1,2M10 insiders · last 365d

Sohi MohsenDirector · Ordinary SharesOther 1 837 @ $212,30$390K · 2026-07-01
Sohi MohsenDirector · Ordinary SharesOther 3 781 @ $71,40$270K · 2026-07-01
Zangerle John AdamSr. VP, Gen Counsel, and Sec. · Ordinary SharesSold 1 419 @ $209,28$297K · 2026-06-15
Carestio Daniel ADirector, President and CEO · Ordinary SharesSold 1 374 @ $212,00$291K · 2026-06-05
Kohler Kenneth ESVP & GM, AST · Ordinary SharesOther 150 @ $212,24$32K · 2026-06-04
Zangerle John AdamSr. VP, Gen Counsel, and Sec. · Ordinary SharesOther 401 @ $212,24$85K · 2026-06-04
Tamaro RenatoV.P. & Corporate Treasurer · Ordinary SharesOther 65 @ $212,24$14K · 2026-06-04
Madsen JuliaSr. VP and GM, Life Sciences · Ordinary SharesOther 195 @ $212,24$41K · 2026-06-04
Fraser Mary ClareSVP & Chief HRO · Ordinary SharesOther 600 @ $212,24$127K · 2026-06-04
Carestio Daniel ADirector, President and CEO · Ordinary SharesOther 1 889 @ $212,24$401K · 2026-06-04
Carestio Daniel ADirector, President and CEO · Ordinary SharesSold 3 054 @ $214,64$656K · 2026-06-04
Burton Karen LSr. Vice Pres., CFO · Ordinary SharesOther 90 @ $212,24$19K · 2026-06-04
Zangerle John AdamSr. VP, Gen Counsel, and Sec. · Ordinary SharesOther 365 @ $210,19$77K · 2026-06-03
Tamaro RenatoV.P. & Corporate Treasurer · Ordinary SharesOther 64 @ $210,19$13K · 2026-06-03
Madsen JuliaSr. VP and GM, Life Sciences · Ordinary SharesOther 239 @ $210,19$50K · 2026-06-03
Kohler Kenneth ESVP & GM, AST · Ordinary SharesOther 184 @ $210,19$39K · 2026-06-03
Fraser Mary ClareSVP & Chief HRO · Ordinary SharesOther 311 @ $210,19$65K · 2026-06-03
Carestio Daniel ADirector, President and CEO · Ordinary SharesOther 2 619 @ $210,19$550K · 2026-06-03
Burton Karen LSr. Vice Pres., CFO · Ordinary SharesOther 190 @ $210,19$40K · 2026-06-03
Majors Cary LSVP and President, Healthcare · Ordinary SharesOther 4 746 · 2026-06-02
Zangerle John AdamSr. VP, Gen Counsel, and Sec. · Ordinary SharesOther 4 359 · 2026-06-02
Zangerle John AdamSr. VP, Gen Counsel, and Sec. · Ordinary SharesOther 247 @ $209,76$52K · 2026-06-02
Tamaro RenatoV.P. & Corporate Treasurer · Ordinary SharesOther 750 · 2026-06-02
Tamaro RenatoV.P. & Corporate Treasurer · Ordinary SharesOther 41 @ $209,76$9K · 2026-06-02
McGowan LindseyVP, Chf. Comp. & Quality Offc. · Ordinary SharesOther 1 155 · 2026-06-02

Short positioning

2.3Mshares short+16.2% vs prior

2.34days to cover

50.2%short of daily vol

1.9Kfails-to-deliver

as of 2026-06-30 · short-interest report (free)

Index membership

S&P 500United States

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

STE.VCanonical

TSX Venture · USD

Intel & risk

PredictorM&A prob3 %Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskLow

No immediate filing-based liquidity or dilution flags were detected.

Relationship graph

This companySectorSubsidiaries

Evidence & claims

From filings & derived data

Operating cash flow (YoY) (2026-03-31 vs 2025-03-31): 16.8%Derived (calculated)
Operating income (YoY) (2026-03-31 vs 2025-03-31): 27.1%Derived (calculated)
Gross margin (FY 2026-03-31): 44.2%Derived (calculated)
R&D expense (YoY) (2026-03-31 vs 2025-03-31): 4.9%Derived (calculated)
Capex (YoY) (2026-03-31 vs 2025-03-31): -0.3%Derived (calculated)
Revenue (YoY) (2026-03-31 vs 2025-03-31): 8.7%Derived (calculated)
Net income (YoY) (2026-03-31 vs 2025-03-31): 27.3%Derived (calculated)
Gross profit (YoY) (2026-03-31 vs 2025-03-31): 9.3%Derived (calculated)
EPS (diluted) (YoY) (2026-03-31 vs 2025-03-31): 27.9%Derived (calculated)
EPS (basic) (YoY) (2026-03-31 vs 2025-03-31): 27.7%Derived (calculated)
Cost of revenue (YoY) (2026-03-31 vs 2025-03-31): 8.3%Derived (calculated)
Net margin (FY 2026-03-31): 13.2%Derived (calculated)
Cost of revenue (annual): USD 3.31BSEC XBRL filing
Gross profit (annual): USD 2.63BSEC XBRL filing
Operating cash flow (annual): USD 1.34BSEC XBRL filing
EPS (basic) (annual): USD-PER-SHARES 8SEC XBRL filing
Pre-tax income (annual): USD 1.05BSEC XBRL filing
Operating income (annual): USD 1.1BSEC XBRL filing
Capex (annual): USD 369MSEC XBRL filing
Total operating expenses (annual): USD 1.52BSEC XBRL filing
R&D expense (annual): USD 112.9MSEC XBRL filing
Revenue (annual): USD 5.94BSEC XBRL filing
Net income (annual): USD 782.3MSEC XBRL filing
EPS (diluted) (annual): USD-PER-SHARES 8SEC XBRL filing

Showing 24 of 60 surfaced claims.

Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

The Thread

Everything we know, in order

2026-07-28EVENTUpcomingQ1 2026 earnings (expected) estimated date

2026-07-03 03:12 UTCHOLDERInstitutional holding changed

2026-07-03 03:12 UTCHOLDER1 institutional position change flagged (1 major)

2026-07-01 03:10 UTCHOLDERInstitutional holding changed

2026-07-01 03:10 UTCHOLDER1 institutional position change flagged (1 major)

2026-07-01INSIDERSohi Mohsen transacted 1.8k sh Ordinary Shares — Director ~$390k

2026-07-01INSIDERSohi Mohsen transacted 3.8k sh Ordinary Shares — Director ~$270k

2026-07-01INSIDERSohi Mohsen disposed of 3.8k sh Director Stock Option (right to buy) — Director

2026-06-15 00:00 UTCINSIDER45 insider transactions — 2026-06 · net sell $3.3M 10 derivative

2026-06-15INSIDERZangerle John Adam sold 1.4k sh Ordinary Shares — Sr. VP, Gen Counsel, and Sec. ~$297k

2026-06-11FILINGDEF 14A filing →

2026-06-05INSIDERCarestio Daniel A sold 1.4k sh Ordinary Shares — Director, President and CEO ~$291k

2026-06-04INSIDERKohler Kenneth E transacted 150 sh Ordinary Shares — SVP & GM, AST ~$32k

2026-06-04INSIDERZangerle John Adam transacted 401 sh Ordinary Shares — Sr. VP, Gen Counsel, and Sec. ~$85k

2026-06-04INSIDERTamaro Renato transacted 65 sh Ordinary Shares — V.P. & Corporate Treasurer ~$14k

2026-06-04INSIDERMadsen Julia transacted 195 sh Ordinary Shares — Sr. VP and GM, Life Sciences ~$41k

2026-06-04INSIDERFraser Mary Clare transacted 600 sh Ordinary Shares — SVP & Chief HRO ~$127k

2026-06-04INSIDERCarestio Daniel A transacted 1.9k sh Ordinary Shares — Director, President and CEO ~$401k

2026-06-04INSIDERCarestio Daniel A sold 3.1k sh Ordinary Shares — Director, President and CEO ~$656k

2026-06-04INSIDERBurton Karen L transacted 90 sh Ordinary Shares — Sr. Vice Pres., CFO ~$19k

2026-06-03INSIDERZangerle John Adam transacted 365 sh Ordinary Shares — Sr. VP, Gen Counsel, and Sec. ~$77k

2026-06-03INSIDERTamaro Renato transacted 64 sh Ordinary Shares — V.P. & Corporate Treasurer ~$13k

2026-06-03INSIDERMadsen Julia transacted 239 sh Ordinary Shares — Sr. VP and GM, Life Sciences ~$50k

2026-06-03INSIDERKohler Kenneth E transacted 184 sh Ordinary Shares — SVP & GM, AST ~$39k

2026-06-03INSIDERFraser Mary Clare transacted 311 sh Ordinary Shares — SVP & Chief HRO ~$65k

2026-06-03INSIDERCarestio Daniel A transacted 2.6k sh Ordinary Shares — Director, President and CEO ~$550k

2026-06-03INSIDERBurton Karen L transacted 190 sh Ordinary Shares — Sr. Vice Pres., CFO ~$40k

2026-06-02INSIDERMajors Cary L transacted 4.7k sh Ordinary Shares — SVP and President, Healthcare

2026-06-02INSIDERZangerle John Adam transacted 4.4k sh Ordinary Shares — Sr. VP, Gen Counsel, and Sec.

2026-06-02INSIDERZangerle John Adam transacted 247 sh Ordinary Shares — Sr. VP, Gen Counsel, and Sec. ~$52k

2026-06-02INSIDERTamaro Renato transacted 750 sh Ordinary Shares — V.P. & Corporate Treasurer

2026-06-02INSIDERTamaro Renato transacted 41 sh Ordinary Shares — V.P. & Corporate Treasurer ~$9k

2026-06-02INSIDERMcGowan Lindsey transacted 1.2k sh Ordinary Shares — VP, Chf. Comp. & Quality Offc.

2026-06-02INSIDERTamaro Renato acquired 2.6k sh Employee Stock Option (right to buy) — V.P. & Corporate Treasurer

2026-06-02INSIDERMcGowan Lindsey acquired 4.0k sh Employee Stock Option (right to buy) — VP, Chf. Comp. & Quality Offc.

2026-06-02INSIDERMajors Cary L acquired 16.5k sh Employee Stock Option (right to buy) — SVP and President, Healthcare

2026-06-02INSIDERMadsen Julia acquired 8.1k sh Employee Stock Option (right to buy) — Sr. VP and GM, Life Sciences

2026-06-02INSIDERKohler Kenneth E acquired 7.7k sh Employee Stock Option (right to buy) — SVP & GM, AST

2026-06-02INSIDERFraser Mary Clare acquired 10.5k sh Employee Stock Option (right to buy) — SVP & Chief HRO

2026-06-02INSIDERZangerle John Adam acquired 15.2k sh Employee Stock Option (right to buy) — Sr. VP, Gen Counsel, and Sec.

Showing the 40 most recent of 61 entries.

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-24 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Derivative transactions

Actions

Ask Handelsavisen

Ownership & reference

Leadership

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread